Medindia

X

Vanderbilt CPPA and rL Solutions form Strategic Alliance to Improve Patient Safety

Thursday, May 15, 2008 General News J E 4
Advertisement
CAMBRIDGE, MA, and NASHVILLE, TN, May 15 /PRNewswire/ - rL Solutions, theleading provider of healthcare quality and safety software, and the Center forPatient and Professional Advocacy (CPPA) at Vanderbilt University MedicalCenter, a leader in risk reduction services, announced today a strategicalliance to improve patient safety.

By combining rL Solutions' industry leading patient feedback system,Feedback MonitorPro(R) (FMPro(R)), with CPPA's innovative assessment tool -the Patient Advocacy Reporting System (PARS(R)) - and intervention servicesdesigned to identify physicians at high risk of medical malpractice claims,both organizations hope to provide the healthcare industry with a powerful newsolution to improve quality, increase patient safety, and reduce risk.

"Our alliance with Vanderbilt CPPA is about as natural as they come," saidSanjay Malaviya, President & CEO, rL Solutions. "Our FMPro solution alreadyprovides organizations with tremendous value through the feedback informationit collects, and by integrating it with CPPA's innovative methodology, we areunlocking a whole new world of value for our clients. It's exciting that wewill be able to bring to market a combined solution that uses patient feedbackto improve quality and safety, and reduce malpractice claims risk."

Under the alliance, rL Solutions will promote CPPA's services to thehealthcare market and will work with CPPA to develop protocols and standardsfor information sharing. rL Solutions and CPPA also plan to collaborate on thecreation of technologies to further enhance the PARS(R) process.

"Our PARS(R) team at the Center for Patient and Professional Advocacy isexcited to work with our thoughtful colleagues at rL Solutions," said Dr.Gerald Hickson, Director of CPPA at Vanderbilt. "Feedback MonitorPro(R)facilitates patients' observations of care, and we've learned how to takethose observations to create a cost-effective program to identify andintervene with physicians and medical center services with high complaintrates who are at increased risk for claims."

One institution that has already taken advantage of the benefits of thetwo complementary systems is the University of Pennsylvania Health System."UPHS has had a very productive experience working with both rL Solutions andCPPA independently," said Dr. Pat Sullivan, UPHS Associate Vice President forClinical Development. "The FMPro(R) system has helped our Patient and GuestServices representatives capture and record our patient and family concerns.The transfer of this data to the Vanderbilt CPPA PARS(R) system has beenseamless and represents an important component of our patient satisfaction andrisk reduction efforts."

About The Center for Patient and Professional Advocacy at Vanderbilt

The Center for Patient and Professional Advocacy promotes patientsatisfaction and quality healthcare through education, research andintervention services while restraining the escalating costs associated withpatient dissatisfaction. CPPA has become a recognized leader in ongoingquality improvement, promotion of patient safety and reduction of malpracticerisk through interventions based on patient and family assessments ofhealthcare services.

About PARS(R)

With more than 12,000 physicians at 29 client sites, CPPA's PARS(R) Systemis designed to analyze and code patient feedback to identify medical staff inhealthcare organizations who may be at increased risk of generatingmalpractice claims. The PARS(R) system includes a guided intervention programwhere peer messengers provide high risk medical staff with comparative data toeffect behavioral change. For more information, please visitwww.mc.vanderbilt.edu/cppa.

About rL Solutions

rL Solutions provides proven risk management, patient feedback, claims andinfection control software to help healthcare organizations improve patient
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Diabetes Drugs Emerge as Top Force in Drug Spendin...
S
Human Genome Sciences Names Kevin P. McRaith Vice ...